These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36176729)

  • 1. Correlations of Microvascular Blood Flow of Contrast-Enhanced Ultrasound and HGF/c-Met Signaling Pathway with Clinicopathological Features and Prognosis of Patients with Hepatocellular Carcinoma [Retraction].
    Onco Targets Ther; 2022; 15():1043-1044. PubMed ID: 36176729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma.
    Zhuang PH; Xu L; Gao L; Lu W; Ruan LT; Yang J
    Onco Targets Ther; 2017; 10():847-857. PubMed ID: 28243120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():281-282. PubMed ID: 37113686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction].
    Onco Targets Ther; 2022; 15():871-872. PubMed ID: 36033902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
    Ang CS; Sun MY; Huitzil-Melendez DF; Chou JF; Capanu M; Jarnagin W; Fong Y; Dematteo RP; D'Angelica M; Allen P; Chen CT; O'Reilly EM; Weiser MR; Abou-Alfa GK
    Anticancer Res; 2013 Aug; 33(8):3241-5. PubMed ID: 23898085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
    Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction].
    Onco Targets Ther; 2022; 15():849-850. PubMed ID: 35975009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():481-482. PubMed ID: 37396311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nrf2 Signaling Pathway in the Radiation Tolerance of Patients with Head and Neck Squamous Cell Carcinoma: An in vivo and in vitro Study [Retraction].
    Onco Targets Ther; 2022; 15():827-828. PubMed ID: 35923472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of SLP-2 in Hepatocellular Carcinoma Tissues and Its Regulation in Cancer Cell Proliferation, Migration, and EMT [Retraction].
    Onco Targets Ther; 2022; 15():869-870. PubMed ID: 36003327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction].
    Onco Targets Ther; 2021; 14():5419-5420. PubMed ID: 34916805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma.
    Ko H; Huh G; Jung SH; Kwon H; Jeon Y; Park YN; Kim YJ
    Food Chem Toxicol; 2020 Aug; 142():111475. PubMed ID: 32522589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction].
    Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
    Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction].
    Onco Targets Ther; 2020; 13():2525. PubMed ID: 32273722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
    Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review).
    Meng W; Chen T
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.